Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Diabetes/Metabolism Research and Reviews|February 11, 2011
Pulmonary fibrosis: a possible diabetic complicationJunling Yang, Qianfei Xue, Lining Miao, et al.Journal of Translational Medicine|January 23, 2024
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosisJie Tan, Qianfei Xue, Xiao Hu, et al.Cytokine|October 12, 2023
Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosisDongyan Ding, Rumei Luan, Qianfei Xue, et al.International Journal of Medical Sciences|March 2, 2023
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A ReviewDongyan Ding, Rong Gao, Qianfei Xue, et al.European Journal of Clinical Nutrition|August 18, 2022
Protective role of zinc in the pathogenesis of respiratory diseasesRumei Luan, Dongyan Ding, Qianfei Xue, et al.Scientific Reports|March 13, 2025
Identification and validation of biomarkers related to ferroptosis in idiopathic pulmonary fibrosisMing Yue, Rumei Luan, Dongyan Ding, et al.Frontiers in Medicine|July 24, 2025
Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19Xiao Hu, Jie Tan, Rumei Luan, et al.International Journal of Oncology|September 8, 2023
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)Xiao Hu, Jin Ren, Qianfei Xue, et al.The American Journal of Chinese Medicine|December 5, 2019
How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma CellsHan Xiao, Qianfei Xue, Qinghua Zhang, et al.Cellular Signalling|July 23, 2025
Blocking IL-6 down-regulates PD-L1 expression and mitigates pulmonary fibrosis by inhibiting the STAT3 signaling pathwayXiao Hu, Jie Tan, Yujuan Wang, et al.Pageof 2